A citation-based method for searching scientific literature

F Rieux-Laucat, F Le Deist, A Fischer. Cell Death Differ 2003
Times Cited: 149







List of co-cited articles
709 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
G H Fisher, F J Rosenberg, S E Straus, J K Dale, L A Middleton, A Y Lin, W Strober, M J Lenardo, J M Puck. Cell 1995
27

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity.
F Rieux-Laucat, F Le Deist, C Hivroz, I A Roberts, K M Debatin, A Fischer, J P de Villartay. Science 1995
26

Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
M C Sneller, J Wang, J K Dale, W Strober, L A Middelton, Y Choi, T A Fleisher, M S Lim, E S Jaffe, J M Puck,[...]. Blood 1997
269
19

The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
S E Straus, E S Jaffe, J M Puck, J K Dale, K B Elkon, A Rösen-Wolff, A M Peters, M C Sneller, C W Hallahan, J Wang,[...]. Blood 2001
304
18

Autoimmune lymphoproliferative syndrome with somatic Fas mutations.
Eliska Holzelova, Cédric Vonarbourg, Marie-Claude Stolzenberg, Peter D Arkwright, Françoise Selz, Anne-Marie Prieur, Stéphane Blanche, Jirina Bartunkova, Etienne Vilmer, Alain Fischer,[...]. N Engl J Med 2004
192
18

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.
R Watanabe-Fukunaga, C I Brannan, N G Copeland, N A Jenkins, S Nagata. Nature 1992
17

Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Hyung J Chun, Lixin Zheng, Manzoor Ahmad, Jin Wang, Christina K Speirs, Richard M Siegel, Janet K Dale, Jennifer Puck, Joie Davis, Craig G Hall,[...]. Nature 2002
495
17

A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.
Manuel Del-Rey, Jesus Ruiz-Contreras, Alberto Bosque, Sara Calleja, Jose Gomez-Rial, Ernesto Roldan, Pablo Morales, Antonio Serrano, Alberto Anel, Estela Paz-Artal,[...]. Blood 2006
78
19

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
J Wu, J Wilson, J He, L Xiang, P H Schur, J D Mountz. J Clin Invest 1996
347
15

NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
João B Oliveira, Nicolas Bidère, Julie E Niemela, Lixin Zheng, Keiko Sakai, Cynthia P Nix, Robert L Danner, Jennifer Barb, Peter J Munson, Jennifer M Puck,[...]. Proc Natl Acad Sci U S A 2007
148
15

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand.
T Takahashi, M Tanaka, C I Brannan, N A Jenkins, N G Copeland, T Suda, S Nagata. Cell 1994
14

Autoimmune lymphoproliferative syndrome.
Michael C Sneller, Janet K Dale, Stephen E Straus. Curr Opin Rheumatol 2003
63
22

The Fas death factor.
S Nagata, P Golstein. Science 1995
14

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
M C Sneller, S E Straus, E S Jaffe, J S Jaffe, T A Fleisher, M Stetler-Stevenson, W Strober. J Clin Invest 1992
231
13

Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.
Austen Worth, Adrian J Thrasher, H Bobby Gaspar. Br J Haematol 2006
109
13

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
C E Jackson, R E Fischer, A P Hsu, S M Anderson, Y Choi, J Wang, J K Dale, T A Fleisher, L A Middelton, M C Sneller,[...]. Am J Hum Genet 1999
162
12

Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
Joao B Oliveira, Jack J Bleesing, Umberto Dianzani, Thomas A Fleisher, Elaine S Jaffe, Michael J Lenardo, Frederic Rieux-Laucat, Richard M Siegel, Helen C Su, David T Teachey,[...]. Blood 2010
254
12

Lymphoproliferative syndrome with autoimmunity: A possible genetic basis for dominant expression of the clinical manifestations.
F Rieux-Laucat, S Blachère, S Danielan, J P De Villartay, M Oleastro, E Solary, B Bader-Meunier, P Arkwright, C Pondaré, F Bernaudin,[...]. Blood 1999
116
11

Fas and Fas ligand: lpr and gld mutations.
S Nagata, T Suda. Immunol Today 1995
809
10

An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
S E Straus, M Sneller, M J Lenardo, J M Puck, W Strober. Ann Intern Med 1999
230
10

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
J Wang, L Zheng, A Lobito, F K Chan, J Dale, M Sneller, X Yao, J M Puck, S E Straus, M J Lenardo. Cell 1999
464
10

FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
Aude Magerus-Chatinet, Marie-Claude Stolzenberg, Maria S Loffredo, Bénédicte Neven, Catherine Schaffner, Nicolas Ducrot, Peter D Arkwright, Brigitte Bader-Meunier, José Barbot, Stéphane Blanche,[...]. Blood 2009
95
10

Activation-induced cell death in T cells.
Douglas R Green, Nathalie Droin, Michael Pinkoski. Immunol Rev 2003
434
9


Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Dana A Obzut, Kelly Axsom, John K Choi, Kelly C Goldsmith, Junior Hall, Jessica Hulitt, Catherine S Manno, John M Maris, Nicholas Rhodin,[...]. Blood 2006
62
14

Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
J J Bleesing, S E Straus, T A Fleisher. Pediatr Clin North Am 2000
61
14

Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim.
David A Hildeman, Yanan Zhu, Thomas C Mitchell, Philippe Bouillet, Andreas Strasser, John Kappler, Philippa Marrack. Immunity 2002
452
8

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.
A K Vaishnaw, J R Orlinick, J L Chu, P H Krammer, M V Chao, K B Elkon. J Clin Invest 1999
124
8

Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
V Koneti Rao, Faith Dugan, Janet K Dale, Joie Davis, Jean Tretler, John K Hurley, Thomas Fleisher, Jennifer Puck, Stephen E Straus. Br J Haematol 2005
76
10

Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Catherine S Manno, Kelly M Axsom, Timothy Andrews, John K Choi, Barbara H Greenbaum, Joseph M McMann, Kathleen E Sullivan, Susan F Travis, Stephan A Grupp. Blood 2005
103
8

Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/- mice.
Salah-Eddine Lamhamedi-Cherradi, Shi-Jun Zheng, Kimberly A Maguschak, Jacques Peschon, Youhai H Chen. Nat Immunol 2003
270
7

Autocrine T-cell suicide mediated by APO-1/(Fas/CD95)
J Dhein, H Walczak, C Bäumler, K M Debatin, P H Krammer. Nature 1995
7

Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.
P Bouillet, D Metcalf, D C Huang, D M Tarlinton, T W Kay, F Köntgen, J M Adams, A Strasser. Science 1999
7


Dominant expression of interleukin 10 but not interferon gamma in CD4(-)CD8(-)alphabetaT cells of autoimmune lymphoproliferative syndrome.
Shouichi Ohga, Akihiko Nomura, Yasushi Takahata, Kenji Ihara, Hidetoshi Takada, Hiroshi Wakiguchi, Yuji Kudo, Toshiro Hara. Br J Haematol 2002
21
33

A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.
Jack J H Bleesing, Margaret R Brown, Cynthia Novicio, David Guarraia, Janet K Dale, Stephen E Straus, Thomas A Fleisher. Clin Immunol 2002
56
12

The CD95(APO-1/Fas) DISC and beyond.
M E Peter, P H Krammer. Cell Death Differ 2003
801
7


Two CD95 (APO-1/Fas) signaling pathways.
C Scaffidi, S Fulda, A Srinivasan, C Friesen, F Li, K J Tomaselli, K M Debatin, P H Krammer, M E Peter. EMBO J 1998
7

Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation.
U Dianzani, M Bragardo, D DiFranco, C Alliaudi, P Scagni, D Buonfiglio, V Redoglia, S Bonissoni, A Correra, I Dianzani,[...]. Blood 1997
129
7


Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity.
Jack Hutcheson, John C Scatizzi, Akbar M Siddiqui, G Kenneth Haines, Tianfu Wu, Quan-Zhen Li, Laurie S Davis, Chandra Mohan, Harris Perlman. Immunity 2008
157
7

Cell-death signaling and human disease.
Frédéric Rieux-Laucat, Alain Fischer, Françoise Le Deist. Curr Opin Immunol 2003
90
7

Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).
David T Teachey, Alix E Seif, Stephan A Grupp. Br J Haematol 2010
62
11

A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation.
Bénédicte Neven, Aude Magerus-Chatinet, Benoit Florkin, Delphine Gobert, Olivier Lambotte, Lien De Somer, Nina Lanzarotti, Marie-Claude Stolzenberg, Brigitte Bader-Meunier, Nathalie Aladjidi,[...]. Blood 2011
87
8

Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.
Aude Magerus-Chatinet, Bénédicte Neven, Marie-Claude Stolzenberg, Cécile Daussy, Peter D Arkwright, Nina Lanzarotti, Catherine Schaffner, Sophie Cluet-Dennetiere, Filomeen Haerynck, Gérard Michel,[...]. J Clin Invest 2011
78
8

T-lymphocyte death during shutdown of an immune response.
Andreas Strasser, Marc Pellegrini. Trends Immunol 2004
145
6

Involvement of APO2 ligand/TRAIL in activation-induced death of Jurkat and human peripheral blood T cells.
M J Martínez-Lorenzo, M A Alava, S Gamen, K J Kim, A Chuntharapai, A Piñeiro, J Naval, A Anel. Eur J Immunol 1998
158
6


Inhibition of death receptor signals by cellular FLIP.
M Irmler, M Thome, M Hahne, P Schneider, K Hofmann, V Steiner, J L Bodmer, M Schröter, K Burns, C Mattmann,[...]. Nature 1997
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.